Avita Medical Inc (RCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RCEL | GALT | ACRV | ||
| Company | Avita Medical Inc | Galectin Therapeutic | Acrivon Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.41 | 3.55 | 9.09 | ||
| High | 8.96 | 3.62 | 9.36 | ||
| Low | 8.40 | 3.46 | 8.09 | ||
| Last | 8.65 | 3.50 | 8.23 | ||
| Change | +0.25 | -0.01 | -0.86 | ||
| % Change | +2.98% | -0.28% | -9.46% | ||
| Volume | 181,538 | 105,817 | 259,095 | ||
| 20-Day Average Volume | 356,107 | 307,471 | 2,236,405 | ||
| Previous Close | 8.40 | 3.51 | 9.09 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 10.50 | 3.56 | 9.04 | ||
| 20-Day Raw Stochastic | 8.37% | 53.67% | 40.81% | ||
| 20-Day Relative Strength | 27.85% | 59.64% | 51.87% | ||
| Weighted Alpha | -43.84 | +71.42 | -51.56 | ||
| Today's Opinion | 72% Sell | 88% Buy | 48% Buy | ||
| Previous Opinion | 56% Sell | 88% Buy | 72% Buy | ||
| Last Month's Opinion | 24% Buy | 100% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.93% since 04/24/24 | +6.38% since 04/24/24 | -13.37% since 04/24/24 | ||
| Low | 8.01 on 04/25/24 | 3.20 on 04/25/24 | 7.80 on 04/25/24 | ||
| High | 8.96 on 05/01/24 | 3.78 on 04/29/24 | 10.16 on 04/29/24 | ||
| 1-Month | |||||
| %Chg | -44.37% since 04/01/24 | +43.44% since 04/01/24 | +13.52% since 04/01/24 | ||
| Low | 8.01 on 04/25/24 | 2.37 on 04/02/24 | 5.70 on 04/08/24 | ||
| High | 15.69 on 04/02/24 | 4.27 on 04/12/24 | 11.90 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | -50.66% since 02/01/24 | +101.15% since 02/01/24 | +113.21% since 02/01/24 | ||
| Low | 8.01 on 04/25/24 | 1.59 on 02/07/24 | 3.19 on 02/13/24 | ||
| High | 18.93 on 02/27/24 | 4.27 on 04/12/24 | 11.90 on 04/09/24 | ||
| 6-Month | |||||
| %Chg | -11.28% since 11/01/23 | +74.13% since 11/01/23 | +62.01% since 11/01/23 | ||
| Low | 8.01 on 04/25/24 | 1.55 on 12/29/23 | 3.19 on 02/13/24 | ||
| High | 18.93 on 02/27/24 | 4.27 on 04/12/24 | 11.90 on 04/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 216,720 | 217,283 | 205,770 | ||
| Shares Outstanding, K | 25,800 | 61,904 | 22,637 | ||
| Annual Sales | 50,140,000 | 0 | 0 | ||
| Annual Net Income | -35,380,000 | -41,070,000 | -60,390,000 | ||
| Last Quarter Sales | 14,200,000 | 0 | 0 | ||
| Last Quarter Net Income | -7,070,000 | -10,000,000 | -19,250,000 | ||
| 60-Month Beta | 1.33 | 0.84 | 1.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.28 on 02/22/24 | -0.16 on 03/29/24 | -0.86 on 03/28/24 | ||
| Latest Earnings Date | 05/13/24 | 05/20/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||